Author Archives: David W. Dawson, Martin E. Fernandez-Zapico
Gemcitabine Activates Natural Killer Cells to Attenuate Pancreatic Cancer Recurrence
With an overall 5-year survival rate of only 7%, pancreatic ductal adenocarcinoma (PDA) has now eclipsed breast cancer as the third leading cause of cancer death in the United States1 and it is predicted to be second by 2030.2 Despite improvements in s… Continue reading
Posted in News
Comments Off on Gemcitabine Activates Natural Killer Cells to Attenuate Pancreatic Cancer Recurrence